Abstract
Get full access to this article
View all access options for this article.
References
1.
Wells
J.A.
,
Gonzales
C.R.
,
Berger
B.B.
,
Gonzalez
V.H.
,
Sippy
B.D.
, and
Burian
G.
A phase 1, open-label, dose-escalation trial to investigate safety and tolerability of single intravitreous injections of ICON-1 targeting tissue factor in wet AMD . Ophthalmic Surg. Lasers Imaging Retina . 49 :336 –345 , 2018 .